The Leveraged Years · AI Regulation Tracker

AI Note Malpractice and the Review Window: What Physicians Owe Before They Sign

AI Regulation Briefing
By Anthony Guerriero, Founder, The Leveraged Years · Reviewed by The Leveraged Years Editorial Desk
First published: June 25, 2026 · Last updated: June 25, 2026

Bindingness: Non-Binding Framework · Scope: United States · Healthcare

A new argument is moving through malpractice suits, and physicians using AI notes should understand it now. Since late 2025, plaintiff lawyers in reported California and Massachusetts matters have introduced a concept they call a "reasonable review window," the idea that a physician had a duty to read an AI-drafted note carefully enough to catch an error before signing. The argument tries to redistribute liability across the signing provider, the vendor, and the system. Here is the honest version: this is an emerging plaintiff-side theory, not settled law. No court has adopted a fixed review window, and the cases are early and unresolved. But the practical lesson is solid and it favors you. When you sign an AI-drafted note, you own it, and a documented, real review habit is your strongest defense against an AI note malpractice claim. This briefing covers what the review window argument is, what to check before you sign, how to document that you reviewed, and how to keep the work HIPAA-safe.

What the reasonable review window argument actually is

The "reasonable review window" is a framing that plaintiff counsel have started using, not a statute and not a defined legal term. The argument runs like this: an AI tool drafted a note, the physician signed it, the note contained an error, and the patient was harmed. Counsel then argues the physician had a duty to review the draft within a reasonable window of attention and care, and failed to do it. In reported California and Massachusetts matters since late 2025, this concept has been raised as a way to attach liability and to spread it across everyone in the chain: the provider who signed, the vendor who built the tool, and the health system that deployed it.

Be clear about the limits of this. No court has defined a specific number of minutes or a fixed standard for what a reasonable review window is. There is no precedent that says reviewing for ninety seconds is enough or that thirty seconds is negligent. These cases are early and most are unresolved. We are not naming case captions, dollar figures, judges, or counts, because the verified picture is that this is an argument being made, covered by health-law and risk commentators, not a body of decided law. Treat it as a signal about where liability theory is heading, not as a rule you can already cite.

Why does an unsettled argument matter to you today? Because the defense against it is something you control completely. The argument only has force if you did not actually review the note. If you read the draft, caught what needed catching, and can show you reviewed, the theory has nothing to land on. The emerging plaintiff framing and the oldest principle in clinical documentation point to the same habit: read before you sign.

You sign it, you own it

This is the part that does not depend on any new legal theory. When your signature goes on a note, you are attesting that it is accurate. That has always been true for dictation, for templates, for copy-forward, and for residents' drafts. An AI draft is no different in this respect. The tool is not the author of record. You are. Liability for an AI note error is managed by skill and habit, not avoided by tool choice. Choosing a different scribe vendor does not transfer your responsibility for what you signed.

This reframes the whole anxiety about AI notes. The fear is usually "what if the AI makes a mistake." The better question is "what is my review habit, and can I show it." A physician with a disciplined pre-sign review is in a strong position whether the draft came from an AI scribe, a template, or a junior colleague. A physician who skims and signs is exposed no matter how the draft was produced. The review is the defense.

What to check before you sign: the review

A reasonable review is concrete. These are the error categories that AI drafts and AI scribes produce, and the ones a signing physician is best placed to catch. Run them every time before you sign.

How to document that you reviewed: a defensible habit

Catching errors is half of it. Being able to show you reviewed is the other half, and it is what answers the review-window argument directly. None of this requires fancy tooling.

• Use clear attestation language. Many groups already use an attestation line for AI-assisted documentation. A short, honest statement that the note was reviewed and edited by the signing physician, and that the physician takes responsibility for its accuracy, is far better than a silent signature. Say what you did.
• Do not skim, read. The defensible habit is an actual read, not a glance at the top of the note. The error categories above live in the middle of the note, in the exam and the plan, exactly where skimming misses them. Reading the whole note is the behavior the standard rewards.
• Give it real time. A reasonable review takes the time a reasonable review takes. You do not need to log a stopwatch, but a workflow that forces a sixty-second sign-and-go on a complex visit is the workflow that creates exposure. Build in the moment to read.
• Prefer a draft you control. A de-identified draft you wrote or dictated after the visit, and then organized with AI, is easier to review honestly than an opaque ambient note you skim because the tool produced it for you. When you are the author and the reviewer, the review is real, not theater.

The contrast matters. An ambient scribe that hands you a polished-looking note invites the exact skimming the review-window argument targets, because the note looks finished. A draft you control invites genuine review because you already know what you put in it. The lower-exposure posture and the better clinical habit are the same posture.

De-identify first: never put PHI into a public model

The safe workflow keeps you the author and keeps the data clean. Instead of feeding identified information to a model, you work from a de-identified draft and re-identify on your side, inside your compliant system. The guardrails:

• Strip every identifier before you paste. Refer to "the patient" or "Patient A." Replace specific dates with relative timing where it still makes the clinical point.
• Keep the clinical signal, drop the identity. The history, exam, and assessment are what the draft needs. The name and the record number are not.
• For any tool that will touch PHI, including an ambient scribe, use only a vendor your organization has vetted under a Business Associate Agreement. A consumer chat interface is not that.
• Re-identify inside your compliant system after the draft comes back, and review the full note before you sign. The model never needs to know who the patient is.

What AI does not replace

AI can draft the note. It does not practice medicine, it does not review the note for you, and it does not carry the responsibility. The boundary is bright and worth stating plainly:

• Clinical judgment stays human. What is wrong with the patient and what to do about it is your determination. The model organizes language; it does not decide the medicine.
• The review itself is yours. No tool reviews its own output on your behalf in any way that protects you. The pre-sign read is the work, and it is work only you can do.
• The attestation is real accountability. When you sign the note, you attest to it. An AI-assisted draft does not dilute that. The review-window argument exists precisely because some signatures came without a real read.
• The responsibility does not transfer. Liability follows the signature, not the vendor. You manage it with a habit, not by hoping the tool got it right.

Related reading: for the recording-consent litigation angle, see our briefing on the AI scribe wiretap lawsuits, the error-catching mechanics in our scribe accuracy review protocol, and the foundations in using AI for clinical notes safely. Track the wider picture in our AI Regulation Tracker series.

Frequently asked questions

What is a reasonable review window for AI notes?

It is an emerging plaintiff-side argument, not settled law. Since late 2025, plaintiff lawyers in reported California and Massachusetts matters have used the phrase to argue that a physician had a duty to review an AI-drafted note carefully before signing. No court has defined a fixed number of minutes or adopted a set standard, and the cases are early and unresolved. The practical takeaway is durable: actually read the note before you sign it.

Am I liable if an AI scribe makes an error in my note?

When you sign the note, you are attesting that it is accurate, so the responsibility for what you signed sits with you regardless of what drafted it. Most of the litigation theory tries to spread liability across the signing provider, the vendor, and the system, but your signature is the anchor. You manage that exposure with a documented, genuine review before signing, not by switching tools.

How do I protect myself from AI note malpractice claims?

Run a real pre-sign review every time: check for fabricated exam findings, wrong medications or doses, wrong laterality, copy-forward errors, and anything you did not personally elicit. Read the whole note rather than skimming, use clear attestation language, and prefer a de-identified draft you control over an opaque note you skim. Never put PHI into a public model. The documented review habit is your strongest defense.